GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Treace Medical Concepts Inc (NAS:TMCI) » Definitions » Piotroski F-Score

Treace Medical Concepts (Treace Medical Concepts) Piotroski F-Score : 3 (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Treace Medical Concepts Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Treace Medical Concepts has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Treace Medical Concepts's Piotroski F-Score or its related term are showing as below:

TMCI' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 5
Current: 3

During the past 5 years, the highest Piotroski F-Score of Treace Medical Concepts was 5. The lowest was 2. And the median was 3.


Treace Medical Concepts Piotroski F-Score Historical Data

The historical data trend for Treace Medical Concepts's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Treace Medical Concepts Piotroski F-Score Chart

Treace Medical Concepts Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
N/A N/A 5.00 2.00 3.00

Treace Medical Concepts Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 4.00 3.00 3.00

Competitive Comparison of Treace Medical Concepts's Piotroski F-Score

For the Medical Devices subindustry, Treace Medical Concepts's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Treace Medical Concepts's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Treace Medical Concepts's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Treace Medical Concepts's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was -12.271 + -17.521 + -6.281 + -18.676 = $-54.7 Mil.
Cash Flow from Operations was -8.335 + -9.513 + 0.532 + -7.221 = $-24.5 Mil.
Revenue was 41.953 + 40.758 + 62.212 + 51.108 = $196.0 Mil.
Gross Profit was 34.278 + 32.76 + 50.743 + 40.981 = $158.8 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(249.17 + 249.643 + 240.36 + 251.907 + 242.726) / 5 = $246.7612 Mil.
Total Assets at the begining of this year (Mar23) was $249.2 Mil.
Long-Term Debt & Capital Lease Obligation was $69.2 Mil.
Total Current Assets was $187.4 Mil.
Total Current Liabilities was $47.0 Mil.
Net Income was -17.234 + -12.133 + -4.412 + -13.454 = $-47.2 Mil.

Revenue was 29.967 + 33.055 + 49.769 + 42.195 = $155.0 Mil.
Gross Profit was 24.676 + 26.965 + 40.748 + 34.156 = $126.5 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(146.512 + 158.722 + 156.443 + 159.024 + 249.17) / 5 = $173.9742 Mil.
Total Assets at the begining of last year (Mar22) was $146.5 Mil.
Long-Term Debt & Capital Lease Obligation was $68.2 Mil.
Total Current Assets was $223.1 Mil.
Total Current Liabilities was $23.3 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Treace Medical Concepts's current Net Income (TTM) was -54.7. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Treace Medical Concepts's current Cash Flow from Operations (TTM) was -24.5. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=-54.749/249.17
=-0.21972549

ROA (Last Year)=Net Income/Total Assets (Mar22)
=-47.233/146.512
=-0.32238315

Treace Medical Concepts's return on assets of this year was -0.21972549. Treace Medical Concepts's return on assets of last year was -0.32238315. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Treace Medical Concepts's current Net Income (TTM) was -54.7. Treace Medical Concepts's current Cash Flow from Operations (TTM) was -24.5. ==> -24.5 > -54.7 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=69.249/246.7612
=0.28063164

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=68.232/173.9742
=0.39219608

Treace Medical Concepts's gearing of this year was 0.28063164. Treace Medical Concepts's gearing of last year was 0.39219608. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=187.397/47.049
=3.9830177

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=223.133/23.296
=9.57816793

Treace Medical Concepts's current ratio of this year was 3.9830177. Treace Medical Concepts's current ratio of last year was 9.57816793. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Treace Medical Concepts's number of shares in issue this year was 61.793. Treace Medical Concepts's number of shares in issue last year was 58.724. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=158.762/196.031
=0.80988211

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=126.545/154.986
=0.8164931

Treace Medical Concepts's gross margin of this year was 0.80988211. Treace Medical Concepts's gross margin of last year was 0.8164931. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=196.031/249.17
=0.78673596

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=154.986/146.512
=1.05783827

Treace Medical Concepts's asset turnover of this year was 0.78673596. Treace Medical Concepts's asset turnover of last year was 1.05783827. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+1+0+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Treace Medical Concepts has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Treace Medical Concepts  (NAS:TMCI) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Treace Medical Concepts Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Treace Medical Concepts's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Treace Medical Concepts (Treace Medical Concepts) Business Description

Traded in Other Exchanges
N/A
Address
100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.
Executives
F Barry Bays director
Betsy Hanna director C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE RD #150, PONTE VEDRA BEACH FL 32081
Deepti Jain director 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sean F. Scanlan officer: See Remarks C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
James T Treace director 117 BRISTOL PLACE, PONTE VEDRA BEACH FL 32082
Richard W Mott director 1221 CROSSMAN AVENUE, SUNNYVALE CA 94089
Thomas E Timbie director
Daniel E. Owens officer: Chief HR Officer C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Scot Michael Elder officer: *See "Remarks" C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Mark Hair officer: Chief Financial Officer C/O RESTORATION ROBOTICS, INC., 128 BAYTECH DRIVE, SAN JOSE CA 95134
Aaron Berutti officer: Sr. VP, Sales C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
John T. Treace director, 10 percent owner, officer: Chief Executive Officer C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Lance A Berry director 5677 AIRLINE ROAD, ARLINGTON TN 38002
Jane E Kiernan director 525 W ROSCOE, CHICAGO IL 60657
John R Treace director 5677 AIRLINE RD, ARLINGTON VA 38002

Treace Medical Concepts (Treace Medical Concepts) Headlines

From GuruFocus

Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock

By Stock market mentor Stock market mentor 02-07-2023